SNDL Inc.

SNDL

CA83307B1013

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.01 ^USD	+3.08%		+7.49%	+22.56%

Apr. 02	Cannabis Stocks Rise Pre-Bell After Florida Supreme Court Allows Ballot Initiative to Legalize Marijuana	MT
Apr. 02	Pot producers climb as recreational cannabis to go on Florida ballot	RE

Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 16, 2022.

November 13, 2023 at 07:12 am EST

From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CAD 0 million. With this, the company has completed the repurchase of 2,863,849 shares, representing 1.21% for CAD 6.35 million under the buyback announced on November 16, 2022.

Latest news about SNDL Inc.

Cannabis Stocks Rise Pre-Bell After Florida Supreme Court Allows Ballot Initiative to Legalize Marijuana	Apr. 02	MT
Pot producers climb as recreational cannabis to go on Florida ballot	Apr. 02	RE
Nova Cannabis Brief: SNDL and Nova Cannabis Announced Overnight Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility	Apr. 02	MT
Nova Cannabis Rises 5% As Swings To Q4 Profit YOY	Mar. 26	MT
Nova Cannabis Swings To Q4 Profit YOY	Mar. 26	MT
Transcript : SNDL Inc., Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
North American Morning Briefing : Investors -2-	Mar. 21	DJ
Earnings Flash (SNDL) SNDL Reports Q4 Revenue $248.5M	Mar. 21	MT
Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 13, 2023.	Mar. 20	CI
Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 16, 2022.	Mar. 20	CI
SNDL Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
SNDL Inc.'s Equity Buyback announced on November 16, 2022, has expired with 2,863,849 shares, representing 1.21% for CAD 6.35 million.	Nov. 29	CI
SNDL, Nova Cannabis Terminate Implementation Agreement; Nova down 11.7%	Nov. 20	MT
SNDL, Nova Cannabis Terminate Implementation Agreement	Nov. 20	MT
SNDL Inc. and Nova Cannabis Inc. Announces the Mutual Decision to Terminate the Implementation Agreement	Nov. 20	CI
Nova Cannabis Inc. cancelled the acquisition of 26 cannabis retail stores located in Ontario and Alberta from SNDL Inc..	Nov. 16	CI
Transcript : SNDL Inc., Q3 2023 Earnings Call, Nov 13, 2023	Nov. 13
SNDL Inc. announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.	Nov. 13	CI
Earnings Flash (SNDL) SNDL Posts Q3 Revenue $237.6M	Nov. 13	MT
Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 16, 2022.	Nov. 13	CI
SNDL Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
SNDL Inc. authorizes a Buyback Plan.	Nov. 12	CI
Nova Cannabis Brief: In addition, SNDL and Nova Extended Maturity date of Nova's revolving credit facility with SNDL to November 30, 2023	23-10-30	MT
Nova Cannabis Brief: SNDL and Nova Cannabis Extending Outside Date for Closing of Strategic Partnership to November 30, 2023; Citing Continued Review by One Provincial Regulator	23-10-30	MT
SNDL to Consolidate Cultivation Activities at Atholville, New Brunswick Facility to Kelowna, British Columbia	23-10-19	MT

Chart SNDL Inc.

Duration

Period

More charts

Company Profile

SNDL Inc. is a Canada-based private-sector liquor and cannabis retailer in Canada with retail banners, which include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, and Firesale Cannabis. Its segments include Liquor Retail, Cannabis Retail, Cannabis Operations and Investments. The Liquor Retail segment includes the sale of wines, beers and spirits through liquor stores. The Cannabis Retail segment includes the private sale of recreational cannabis through and franchise retail cannabis stores. The Cannabis Operations segment includes the cultivation, distribution and sale of cannabis for the adult-use and medical markets domestically and for export, and providing cannabis processing services, in addition to product development, manufacturing, and commercialization of cannabis consumer packaged goods. The Investments segment includes the deployment of capital to investment opportunities. Its cannabis brand portfolio includes Top Leaf, Vacay, Grasslands and others.

Sector

Pharmaceuticals

Calendar

2024-05-08 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for SNDL Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.752 CAD

Average target price

4.92 CAD

Spread / Average Target

+78.79%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SNDL INC.	+22.56%	529M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals

SNDL Inc.

Equities

SNDL

CA83307B1013

Pharmaceuticals

Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 16, 2022.

EPS Revisions